Mother Urges FDA to Expedite Rare Disease Treatment Approvals

A mother of a son with Duchenne muscular dystrophy is urging FDA Commissioner Makary to prioritize and accelerate the approval process for treatments for rare diseases, citing the impact of delays on families.